TY  - GEN
AU  - Hartl,D M
AU  - Bahleda,R
AU  - Hollebecque,A
AU  - Bosq,J
AU  - Massard,C
AU  - Soria,J C
TI  - Bevacizumab-induced laryngeal necrosis
SN  - 1569-8041
PY  - 2012///0411
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Antibodies, Monoclonal, Humanized
KW  - adverse effects
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bevacizumab
KW  - Carboplatin
KW  - administration & dosage
KW  - Cisplatin
KW  - Clinical Trials, Phase I as Topic
KW  - Deoxycytidine
KW  - Female
KW  - Glutamates
KW  - Guanine
KW  - Humans
KW  - Laryngeal Diseases
KW  - chemically induced
KW  - Lung Neoplasms
KW  - Middle Aged
KW  - Necrosis
KW  - Neoplasm Recurrence, Local
KW  - Paclitaxel
KW  - Pemetrexed
KW  - Tubulin Modulators
KW  - Gemcitabine
N1  - Publication Type: Case Reports; Letter
UR  - https://doi.org/10.1093/annonc/mdr515
ER  -